This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Pharma Mar, S.a.. Active years: 2008-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tres Cantos, ES (2008)
- Madrid, ES (2010)
Company Filing History:
Years Active: 2008-2010
Title: Felix Cuevas: Innovator in Antitumoral Research
Introduction
Felix Cuevas is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumoral agents. With a total of 2 patents to his name, Cuevas is recognized for his innovative approaches to cancer treatment.
Latest Patents
His latest patents focus on synthetic methods for aplidine and new antitumoral derivatives. These inventions relate to aplidine derivatives of a general formula that are useful for the treatment of tumors. The methods of making and using these derivatives represent a significant advancement in cancer therapy.
Career Highlights
Felix Cuevas is currently employed at Pharma Mar, S.A., a company known for its dedication to developing innovative therapies for cancer. His work at Pharma Mar has positioned him as a key player in the pharmaceutical industry, contributing to groundbreaking research and development.
Collaborations
Throughout his career, Cuevas has collaborated with notable colleagues, including Ignacio Rodriguez and Concepción Polanco. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in research.
Conclusion
Felix Cuevas is a distinguished inventor whose work in antitumoral research has the potential to impact cancer treatment significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile